Dysis ii acs china

Author: gfdd

August undefined, 2024

WebContemporary data from the DYSIS II ACS/CHD study These observational data show the progress made in the treatment of ACS from the acute phase up to 3 months, and highlight key areas for improvement in the prevention of recurrent events in patients with CHD in … WebMethods: The Dyslipidemia International Study (DYSIS) II was a multinational, observational study that enrolled patients over 18 years of age who were hospitalised with an ACS in …

Low-density lipoprotein cholesterol target achievement in patients ...

WebOct 15, 2024 · The results from this real-world DYSIS II study in post-ACS patients from China suggest that less than one-fifth (17.1%) of patients were at LDL-C goal of <1.8 … WebProducts. DYSIS Medical is a forward-looking medical technology company that combines innovative computer-aided cervical mapping with an advanced colposcope design to help … damon parthesius

Lipid Goal Attainment in Post-acute Coronary …

WebThe DYSIS II Europe study which included patients with coronary heart disease (CHD) and survivors of acute coronary syndrome (ACS) from 7 European countries (Belgium, France, Germany, Greece, Ireland, Italy, and Russia) showed that only 28.3% of CHD patients and 15.7% of ACS patients had attained the target LDL cholesterol level of <70 mg/dL. WebAug 28, 2024 · Background: The objective of the second Dyslipidemia International Study (DYSIS II) was to document use of lipid-lowering therapies (LLTs), LDL-C target value a We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. WebAug 29, 2024 · Despite major progress in the diagnosis and treatment, cardiovascular disease (CVD) remains a leading cause of death, premature disability and increasing healthcare costs worldwide. According to the World Health Organization, of the 56.4 m deaths in 2015, CVD accounted for 15 m, around 7.4 m from coronary heart disease … damon paramore in texas

Original Study

WebNov 16, 2024 · A large observational study (DYSIS-China) showed that although the majority ... In the DYSIS II ACS cohort, 11 although 94.6% of patients still used statins 4 months after discharge, the statin dosage … WebJul 9, 2024 · To document the prevalence of lipid abnormalities and the achievement of lipid targets among patients surviving an ACS and in patients with stable coronary heart disease (CHD), using data from the DYSIS II study. Methods . DYSIS II was an observational cross-sectional study conducted in 21 countries (2012–2014). We report data from the French ... bird picks up kidWebUsing data from the observational DYSIS II study, we sought to evaluate the use of guideline-recommended treatments at discharge for acute coronary syndromes (ACS) or in the chronic phase for CHD, and participation in … damon pichoff

"WebOct 15, 2024 · The results from this real-world DYSIS II study in post-ACS patients from China suggest that less than one-fifth (17.1%) of patients were at LDL-C goal of <1.8 … " - Dysis ii acs china

Dysis ii acs china

Use of guideline-recommended management in …

WebWith advanced DYSIS colposcopy exams, acetowhitening is objectively quantified, which can help reduce the risk of missing high-grade disease. 4. 3. DeNardis et al. Int J … WebNov 1, 2024 · The DYSIS II (Dyslipidemia International Study II) was a multinational observational study in adults with established CHD, presenting as either an ACS or …

Did you know?

WebMar 1, 2024 · Methods. The Dyslipidemia International Study (DYSIS) II was a multinational, observational study that enrolled patients over 18 years of age who were hospitalised with an ACS in 2013–2014 and survived until discharge. Patients were analysed according to whether or not they were treated with LLT prior to hospital admission. A lipid profile was … WebBackground: Effective management of hyperlipidemia is of utmost importance for prevention of recurring cardiovascular events after an acute coronary syndrome (ACS). Indeed, guidelines recommend a low-density lipoprotein cholesterol (LDL-C) level of <70 mg/dL for such patients. The Dyslipidemia International Study II (DYSIS II) - Egypt was initiated in …

WebNov 1, 2024 · Using data from the observational DYSIS II study, we sought to evaluate the use of guideline-recommended treatments at discharge for acute coronary syndromes (ACS) or in the chronic phase for CHD, and participation in rehabilitation/secondary prevention programs. Methods and results: WebLearn about Equinix DC2 carrier-neutral data center, located at 21715 Filigree Court, Ashburn, VA. See our interconnection options, certifications and more.

WebA large observational study (DYSIS-China) showed that although the majority ... In the DYSIS II ACS cohort, 11 although 94.6% of patients still used statins 4 months after discharge, the statin dosage decreased from 37 mg during the hospital stay to 32±21 mg/day by the follow-up visit. Despite this comparatively high dose of statin, attainment ... WebACS patients had a repeat lipid test during the follow-up period. Although LDL cholesterol target attainment had improved after discharge, only two-ﬁfths (42%) of patients achieved LDL cholesterol <70mg/dl during the follow-up. The DYSIS II results are in accordance with other multinational surveys in the Asia-Paciﬁc region,

WebNov 25, 2024 · The Dyslipidemia International Study (DYSIS II) prospectively collected data of patients with chronic coronary syndromes (CCS) and acute coronary syndromes …

Webwith ACS in China. We report on patterns of LLT, and LDL-C goal attainment at baseline (ACS) and at 6 months post-ACS in China. 2 METHODS DYSIS II-China was a … damon pierce footballWebApr 10, 2024 · The Dyslipidemia International Study (DYSIS) II was a multinational observational study involving subjects with stable CHD and those being hospitalized with an ACS. The present ... considered to be at very high-risk due to the ACS event, LDL-C target attainment was evaluated for any subjects with a repeat lipid profile available. bird pictures 4kWebAug 29, 2024 · Background: The objective of the second Dyslipidemia International Study (DYSIS II) was to document use of lipid-lowering therapies (LLTs), LDL-C target value attainment (LDL-C <70 mg/dL) at the time of the acute event and at 4-months follow-up in patients with acute coronary syndrome (ACS). Methods: The ACS cohort of DYSIS II … damon on the vampire diariesWebAug 15, 2024 · LLT was widely employed following the ACS, though LDL-C target achievement was poor ... (DYSIS) II included patients hospitalized for an ACS. Lipid levels and use of lipid-lowering therapy (LLT) were evaluated at baseline and 4 months post-discharge. The proportions of patients attaining the recommended LDL-C target for … damon palmer in cursive writingWebJan 30, 2024 · DYSIS represents a technological advancement in the identification and management of cervical dysplasia and cancer prevention." Jeff Livingston MD, FACOG … bird pictures and namesWebDysis Inc was founded in 1993, and is located at 12024 Sunrise Valley Dr in Reston. Additional information is available at or by contacting Joseph Lenning at (703) 715-3018. bird pictures animatedWebSep 21, 2024 · The results were from an observational, cross-sectional, multinational DYSIS* II study, which enrolled 4,592 patients comprising 2,794 with stable CHD (mean age 63.7 years, 78.6 percent men) and 1,798 hospitalized with an acute coronary syndrome (ACS; mean age 62.2 years, 74.3 percent men) across nine Asia-Pacific countries … damon pichoff attorney